Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
NOAC Monotherapy Noninferior to Combo Therapy Post-DES
Added: 2 weeks ago Source:  Arrhythmia Academy
In atrial fibrillation (AF) patients post one-year drug-eluting stent (DES) implantation, non–vitamin K antagonist oral anticoagulant (NOAC) was shown to be noninferior to NOAC plus clopidogrel combination therapy.¹ Current guidelines recommend NOAC monotherapy in this patient population, but supporting evidence has been limited.²MethodologyThe ADAPT AF-DES trial was a multicenter, randomised,… View more

Anticoagulation

Electrophysiology & Arrhythmia
ESC 25: SWEDEPAD 1 and 2
Author(s): Marten Falkenberg , Joakim Nordanstig Added: 6 months ago
ESC Congress 2025 - Paclitaxel-coated devices in critical limb threatening ischemia were not effective in preventing amputation, nor improving quality-of-life in intermittent claudication.Dr Mårten Falkenberg (Sahlgrenska University Hospital, Gothenburg, SE) and Prof Joakim Nordanstig (Sahlgrenska University Hospital, Gothenburg, SE) join us to discuss findings from the SWEDEPAD 1 and 2 parallel… View more

Intervention

Vascular Disease and Surgery
EuroPCR 24: The CAGEFREE II Trial
Author(s): Ling Tao Added: 1 year ago
EuroPCR 2024 — Investigator, Dr Ling Tao joins us to discuss the findings from the CAGEFREE II trial.Compared to drug-eluting stents, drug-coated balloons are associated with faster vessel healing and reduced thrombotic burden, therefore patients treated with DCBs require a less intensive antiplatelet therapy. CAGEFREE II investigated the effectiveness and safety of a tailored one-month DAPT… View more

Intervention
EuroPCR 25: BIOADAPTOR RCT 3Y Outcomes
Author(s): Shigeru Saito Added: 9 months ago
EuroPCR25 - Novel DynamX Bioadaptor demonstrates a sustained reduction of device-related events from six-month to three-year follow-up compared to drug-eluting stents (DES).We are joined by Dr Shigeru Saito (Shonan Kamakura General Hospital, Kamakura, JP) to discuss key findings from the BIOADAPTOR RCT trial (NCT04192747). This prospective, randomised controlled trial compared the ELX1805J … View more

Intervention

Vascular Disease and Surgery
SUCCESS PTA: 12-Month Data from SELUTION SLR™ DEB
Author(s): Michael Lichtenberg Added: 10 months ago
12 Month Outcomes of the SUCCESS PTA Study show consistent safety and effectiveness in claudicant and CLTI patients when using the SELUTION SLR™ drug eluting balloon.Dr Michael Lichtenberg (Vascular Centre Clinic Arnsberg, Arnsberg, DE) joins us to discuss the SUCCESS PTA study, a prospective, observational global registry evaluating the SELUTION SLR DEB in 723 patients across Europe, Asia and… View more

Intervention

Vascular Disease and Surgery
ACC 25: The SMART-CHOICE 3 Trial
Author(s): Joo-Yong Hahn Added: 11 months ago
ACC 25 - SMART-CHOICE 3 Trial finds clopidogrel monotherapy to be the optimal anti-thrombotic strategy in high risk patients with contemporary drug-eluting stents.Dr Joo-Yong Hahn (Samsung Medical Center, Seoul, KR) joins us onsite at ACC Conference 2025 to discuss the findings from the SMART-CHOICE 3 study (NCT04418479). The study aims to evaluate the efficacy and safety of clopidogrel… View more

Anticoagulation

Intervention
ESC 24: Day 4 Wrap-Up with Dr Alasnag and Dr Al-Shaibi
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 1 year ago
ESC Congress 24 – Day 4 of the ESC Congress 2024 was filled with hot line and late-breaking data poised to influence cardiovascular practice.Interventional experts DrMirvat Alasnagand DrKhaled Al-Shaibi(King Fahd Armed Forces Hospital, SA) joined us to review and distil the key messages from the latest data presented at the last of the biggest cardiovascular event of 2024.Day 4 Highlights:00:19… View more

Imaging & Diagnostics

Intervention
Hypertrophic Cardiomyopathy: a Review
Author(s): Sukriti Banthiya , Larissa Check , Jessica Atkins Added: 1 year ago

Heart Failure
Angela Hoye
Research Area(s) / Expertise: Job title: Consultant Cardiologist
Angela Hoye is an Interventional Cardiologist at Castle Hill Hospital, Hull and a Senior Lecturer in Cardiology at the Centre for Cardiovascular and Metabolic Research, Hull York Medical School. She completed cardiology training in East Yorkshire, UK and has a speciality interest in coronary intervention. She worked for two years at the Thoraxcenter, Rotterdam between 2002 and 2004, and… View more
NVM Cardiology Meeting Reflections: What's Hot at TCT 25?
Author(s): Nicolas M Van Mieghem Added: 4 months ago
NVM Cardiology Conference Reflections: What’s Hot at TCT 2025?Join Prof Nicolas Van Mieghem, Transcatheter Interventions Online Course Director, as he shares his critical perspective on some of the key late-breaking data highlights from TCT 2025.What should we expect from the new data? Where should we take a closer look at the existing evidence and the premise of these trials? And which results… View more

Intervention